Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

06. Septembre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1982


	Articles 1 - 20 / 39621

	Spectral CT-based Nomogram for Noninvasive Assessment and Prognostic Prediction of MSI/dMMR in Esophagogastric Junction Adenocarcinoma. Radiol Imaging Cancer Wu Y, Lin K, Lin N, Lin Y, Huang X, Wang M, She D, Cao D. PMID: 42695789 [PubMed - indexed for MEDLINE]
	Goal-directed nutritional support in preserving muscle mass and optimising recovery in treatment of oesophageal cancer: results of a prospective non-randomised cluster trial. Support Care Cancer Barth I, Stelwagen I, Weerink LBM, Dijk DG, Meinders H, Milovanovic M, Haveman JW, van Det MJ, Dijkstra G, Campmans-Kuijpers MJE. PMID: 42693322 [PubMed - indexed for MEDLINE]
	Prevalence of Claudin 18.2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma: A Systematic Review and Meta-Analysis. J Gastrointest Cancer Khan FE, Majumdar R, Dodeja M, Alves GAM, Harby A, Siddiqui R, Madappattuparambil S. PMID: 42690279 [PubMed - indexed for MEDLINE]
	Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Clin Exp Med Zhang YF, Xie JJ, Wu Q, Zhou XY, Zeng C, Zeng Y, He YM, Guo M, Teng FY, Xu Y. PMID: 42690254 [PubMed - indexed for MEDLINE]
	A real-world multicenter study on postoperative adjuvant treatment patterns and prognostic implications following neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma. Front Immunol Zhang X, Gao H, Cao J, Gao M, Xu Y, Zhang W, Qian P, Liu X, Fu Z, Shen W. PMID: 42688471 [PubMed - indexed for MEDLINE]
	The efficacy and safety of pembrolizumab in the treatment of HER2-negative advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis of emerging clinical data. Front Immunol Yang Y, Jiang L, Zhang G, Li K, Li D. PMID: 42688407 [PubMed - indexed for MEDLINE]
	The role of circulating tumor DNA (ctDNA) to detect minimal residual disease in locally advanced gastroesophageal carcinoma: the BUTTERFLY study. ESMO Gastrointest Oncol Puccini A, Paracchini L, Alfieri R, Ancona L, Daprà V, Migliaccio G, Cammarota A, Mannarino L, Bartolini M, Miele V, Airaghi C, Beltrame L, Rella A, Mella G, Piemontese M, Pansa A, Garbarino GM, Basato S, Capogreco A, Franceschini D, D'Orazio F, Fraticelli S, Pistillo D, Spaggiari P, Laghi A, Hassan C, Scorsetti M, Repici A, Janjigian YY, Castoro C, Santoro A, Marchini S. PMID: 42688382 [PubMed]
	Precision Oncology in Gastrointestinal and Colorectal Cancer Surgery. Hematol Oncol Clin North Am McDonald HG, Kerekes DM, Kim J, Khan SA. PMID: 42686330 [PubMed - indexed for MEDLINE]
	Oncological outcomes and recurrence patterns after robot-assisted versus video-assisted esophagectomy for cT3br/cT4b esophageal cancer. Dis Esophagus Abe T, Higaki E, Hosoi T, Inada K, Ozaki K, An B, Yamaguchi J, Komori K, Ito S. PMID: 42685263 [PubMed - indexed for MEDLINE]
	Neoadjuvant immunochemotherapy with or without radiotherapy for locally advanced esophageal squamous cell carcinoma: a pooled analysis of two prospective single-arm clinical trials. Int J Surg Li Y, Jiang M, Zhu Z, Xu Y, Jiang F, Feng D, Cao G, Song X, Zhao L, Kong C, Wu Y, Gu L, Huang X, Guo Z, Zhang J, Yang B, Xiao G, Zhao Y, Ye J, Jiang N, Zhu X. PMID: 42682320 [PubMed]
	Beyond Zolbetuximab: Next-Generation Targeting Strategies for CLDN18.2. J Gastrointest Cancer Sagawa T, Nagashima H, Fujikawa K. PMID: 42681308 [PubMed - indexed for MEDLINE]
	Standard reporting on duodenal stump leakage after gastric cancer resections: multicentre analysis from the GASTRODATA Study Group (the STARDUST study). Br J Surg Molteni M, Puccetti F, Baiocchi GL, Piessen G, Allum W, Davies A, Hoelscher A, Gockel I, Reim D, Morgagni P, Fumagalli Romario U, D'Ugo D, Reddavid R, De Manzoni G, van Sandick J, Gisbertz S, Wijnhoven B, Polkowski W, Ko, Kielan W, Matos da Costa P, Lara Santos L, Pera M, Moenig S, Schneider PM, Gutschow CA, Elmore U, Rosati R, Other Members of the GASTRODATA Study Group. PMID: 42678183 [PubMed - indexed for MEDLINE]
	Associations Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Cancer Risk: A Systematic Review and Meta-Analysis. Cancer Control Lalani I, Nambayan R, Carbonell C, Ruan Y, O'Sullivan DE, Stukalin I, Hilsden RJ, Brenner DR. PMID: 42677883 [PubMed - indexed for MEDLINE]
	From dysbiosis to precision oncology: translational role of the microbiome in gastrointestinal cancer. Cell Cycle Adam M, Venugopal A, Almohana A, Awadallah M, Purohit P, Abid A, Jose E, Rajendiran A, Banka P, Ilipilla C, Bhuvan F, Rai M. PMID: 42677508 [PubMed - indexed for MEDLINE]
	For Advanced Oesophageal Squamous Cell Carcinoma, PD-1 Antibody Combined with Chemotherapy Improves Progression-Free Survival Compared with Monotherapy or Chemotherapy Alone as First-Line Treatment: A Retrospective Study with Prognostic Biomarker Analysis. Drug Des Devel Ther Ju F, Ji Y. PMID: 42677252 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Salvage Surgery After Proton Beam-Based Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: A Case Series Study. Ann Surg Oncol Kakinuma H, Honda M, Hori S, Yamamoto R, Nishino K, Takagawa Y, Suzuki N, Takano Y. PMID: 42675350 [PubMed - as supplied by publisher]
	Comparative Evaluation of Short-term Outcomes Between Initial and Later Periods After Introduction of Robot-assisted Surgery for Esophageal Cancer. Anticancer Res Hamai Y, Ibuki Y, Ohsawa M, Kitasaki N, Kishi N, Kurokawa T, Okada M. PMID: 42674705 [PubMed - indexed for MEDLINE]
	Integrated Spatial Immune Phenotyping Identifies a Suppressive-infiltrated High-risk Subgroup in Esophageal Squamous Cell Carcinoma. Anticancer Res Jiao W, Wang D, Han J, Liu Y, Yamada S. PMID: 42674688 [PubMed - indexed for MEDLINE]
	Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial. Eur J Cancer Rühle A, Krause A, O'Connell RL, Simes J, Michael M, Smithers BM, Wong RKS, Haustermans K, Nicolay NH, Leong T, Lordick F. PMID: 42673704 [PubMed - as supplied by publisher]
	Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil-Induced Neutropenia on Histological Tumor Response in Esophageal Squamous Cell Carcinoma: A Retrospective Study. Oncology Inagaki T, Sato M, Kin M, Otsuka K, Murakami M, Kogo M. PMID: 42671950 [PubMed - as supplied by publisher]

Articles 1 - 20 / 39621

Page 1 de 1982



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité